Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACCS100 for reduction of dietary mycotoxin exposure
NCT01677195Phase 2Completed
- Sponsor
- Texas EnteroSorbents
- Start
- Sep 2012
- Primary completion
- Aug 2014
- Countries
- 1
01
Overview
A Phase 2 trial of ACCS100 in dietary carcinogenesis, hepatocellular carcinoma (HCC), sponsored by Texas EnteroSorbents. Started Sep 2012; status: completed.
02
Drugs
ACCS100
03
Conditions
dietary carcinogenesishepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT01677195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01677195.